BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 32515685)

  • 1. Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19.
    Liu P; Cai J; Jia R; Xia S; Wang X; Cao L; Zeng M; Xu J
    Emerg Microbes Infect; 2020 Dec; 9(1):1254-1258. PubMed ID: 32515685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data.
    Xu CLH; Raval M; Schnall JA; Kwong JC; Holmes NE
    Pediatr Infect Dis J; 2020 Sep; 39(9):e249-e256. PubMed ID: 32618932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal viral shedding in COVID-19 patients: Clinical significance, viral load dynamics and survival analysis.
    Wang X; Zheng J; Guo L; Yao H; Wang L; Xia X; Zhang W
    Virus Res; 2020 Nov; 289():198147. PubMed ID: 32866537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Viral Severe Acute Respiratory Syndrome Coronavirus 2 RNA Shedding in Children: Preliminary Data and Clinical Consideration from a Italian Regional Center.
    De Ioris MA; Scarselli A; Ciofi Degli Atti ML; Ravà L; Smarrazzo A; Concato C; Romani L; Scrocca R; Geremia C; Carletti M; Calò Carducci FI; Bernardi S; Coltella L; Santilli V; Chiurchiu S; Peschiaroli E; Mariani R; Marabotto C; Perrotta D; Villani A; Rossi P; D'Argenio P; Campana A; Raponi M
    J Pediatric Infect Dis Soc; 2020 Jul; 9(3):366-369. PubMed ID: 32444874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul, South Korea.
    Han MS; Seong MW; Kim N; Shin S; Cho SI; Park H; Kim TS; Park SS; Choi EH
    Emerg Infect Dis; 2020 Oct; 26(10):2497-2499. PubMed ID: 32497001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.
    Chen Y; Chen L; Deng Q; Zhang G; Wu K; Ni L; Yang Y; Liu B; Wang W; Wei C; Yang J; Ye G; Cheng Z
    J Med Virol; 2020 Jul; 92(7):833-840. PubMed ID: 32243607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viable SARS-CoV-2 in various specimens from COVID-19 patients.
    Jeong HW; Kim SM; Kim HS; Kim YI; Kim JH; Cho JY; Kim SH; Kang H; Kim SG; Park SJ; Kim EH; Choi YK
    Clin Microbiol Infect; 2020 Nov; 26(11):1520-1524. PubMed ID: 32711057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virological assessment of hospitalized patients with COVID-2019.
    Wölfel R; Corman VM; Guggemos W; Seilmaier M; Zange S; Müller MA; Niemeyer D; Jones TC; Vollmar P; Rothe C; Hoelscher M; Bleicker T; Brünink S; Schneider J; Ehmann R; Zwirglmaier K; Drosten C; Wendtner C
    Nature; 2020 May; 581(7809):465-469. PubMed ID: 32235945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent severe acute respiratory syndrome coronavirus 2 detection after resolution of coronavirus disease 2019-associated symptoms/signs.
    Park SY; Yun SG; Shin JW; Lee BY; Son HJ; Lee S; Lee E; Kim TH
    Korean J Intern Med; 2020 Jul; 35(4):793-796. PubMed ID: 32549526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).
    Xu K; Chen Y; Yuan J; Yi P; Ding C; Wu W; Li Y; Ni Q; Zou R; Li X; Xu M; Zhang Y; Zhao H; Zhang X; Yu L; Su J; Lang G; Liu J; Wu X; Guo Y; Tao J; Shi D; Yu L; Cao Q; Ruan B; Liu L; Wang Z; Xu Y; Liu Y; Sheng J; Li L
    Clin Infect Dis; 2020 Jul; 71(15):799-806. PubMed ID: 32271376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay.
    Bordi L; Sberna G; Lalle E; Piselli P; Colavita F; Nicastri E; Antinori A; Boumis E; Petrosillo N; Marchioni L; Minnucci G; D'Agostini E; Castilletti C; Locatelli F; Zumla A; Ippolito G; Capobianchi MR; On Behalf Of Inmi ReCOVeRI Study Group
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33092065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19.
    Corsini Campioli C; Cano Cevallos E; Assi M; Patel R; Binnicker MJ; O'Horo JC
    J Clin Virol; 2020 Sep; 130():104577. PubMed ID: 32777762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
    Shi D; Wu W; Wang Q; Xu K; Xie J; Wu J; Lv L; Sheng J; Guo J; Wang K; Fang D; Li Y; Li L
    J Infect Dis; 2020 Aug; 222(6):910-918. PubMed ID: 32614392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
    Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies.
    Guo X; Zeng L; Huang Z; He Y; Zhang Z; Zhong Z
    Front Immunol; 2020; 11():1936. PubMed ID: 32849650
    [No Abstract]   [Full Text] [Related]  

  • 16. Value of swab types and collection time on SARS-COV-2 detection using RT-PCR assay.
    Liu M; Li Q; Zhou J; Ai W; Zheng X; Zeng J; Liu Y; Xiang X; Guo R; Li X; Wu X; Xu H; Jiang L; Zhang H; Chen J; Tian L; Luo J; Luo C
    J Virol Methods; 2020 Dec; 286():113974. PubMed ID: 32949663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019.
    He Y; Luo J; Yang J; Song J; Wei L; Ma W
    Front Cell Infect Microbiol; 2020; 10():445. PubMed ID: 32850506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibodies mediate virus-immune pathology of COVID-19.
    Jacobs JJL
    Med Hypotheses; 2020 Oct; 143():109884. PubMed ID: 32512289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau.
    Lo IL; Lio CF; Cheong HH; Lei CI; Cheong TH; Zhong X; Tian Y; Sin NN
    Int J Biol Sci; 2020; 16(10):1698-1707. PubMed ID: 32226287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
    Basu A; Zinger T; Inglima K; Woo KM; Atie O; Yurasits L; See B; Aguero-Rosenfeld ME
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32471894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.